Boehringer image

Boehringer seeks more indications for IPF drug

October 22, 2014
Research and Development, Sales and Marketing Boehringer, IPF, NSCLC, colectoral, crc, nintedanib, ofev

Boehringer Ingelheim’s nintedanib has entered Phase III studies for the treatment of colorectal cancer (CRC), which could add to the …

Mark Baker image

NICE under increased pressure over conflicts of interest

October 22, 2014
Sales and Marketing GPs, NHS, NICE, UK, baker, conflict, mccoll, wollaston

A group of influential doctors is calling on the government to tighten up NICE’s conflicts of interests policy. In a …

michael_giske_epic

Epic Sciences hires chief information officer

October 22, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Giske, epic sciences

San Diego-based diagnostics development firm Epic Sciences has appointed Michael Giske as its chief information officer. Giske has more than …

james_bowling

Shire interim chief financial officer resigns

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Shire, james bowling, merger

Shire’s interim chief financial officer James Bowling has left the firm for water company Severn Trent following the collapse of …

arthur_roach

Parkinson’s UK appoints research director

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arthur Roach, Parkinson's UK

Charity organisation Parkinson’s UK has appointed a leading pharma industry expert in Dr Arthur Roach as its research director. Roach …

shire_image_1

AbbVie ditches Shire as tax deal falters

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Obama, Shire, US government, tax, tax inversion

Tax rule changes coming from the US government have forced the collapse of a multi-billion dollar deal between Humira manufacturer …

Lord Maurice Nathan Saatchi image

Medicine Innovation Bill a step closer in UK

October 20, 2014
Sales and Marketing BBC, DH, NHS, innovation bill, saatchi

A new bill proposed by Conservative peer Lord Saatchi has been given government backing as it seeks to become law …

wayne_paterson

Admedus appoints two board directors

October 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Seaberg, Wayne Paterson, admedus

Australian-based healthcare product development firm Admedus has appointed two new directors to its board. John Seaberg and Wayne Paterson (pictured) …

Pharmacists could save the NHS £1.1 billion

October 20, 2014
Sales and Marketing GP, GPs, NHS, UK, pharmacists

New research from the Royal Pharmaceutical Society shows that common ailments such as coughs and sore throats cost the NHS …

Bing image

Working Life: MedImmune’s Dr Bing Yao

October 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MedImmune, Working Life, bing yao

 How did you find your way into your current role? When I was pursuing my doctorate in microbiology and immunology, …

Ebola image

GSK: Ebola vaccines will come ‘too late’

October 17, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp

GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …

Roche image

Roche and Pharmacyclics agree leukaemia pact

October 17, 2014
Research and Development, Sales and Marketing BMS, CLL, Cancer, Gazyva, Pharmacyclics, Roche, imbruvica, leukaemia

Pharmacyclics’s cancer drug Imbruvica will be tested in combination with Roche’s Gazyva in a new partnership announced by the firms. …

Woodley commemorates 25 years in the industry

October 17, 2014
Manufacturing and Production, Sales and Marketing Manchester, Supply, development, manufacturing, wickham, woodley

Medical supplier firm Woodley celebrated its 25-year anniversary this month at a lavish event at The Runway Visitor Park in …

Mobile telehealth to create ‘doctor in your pocket’ convenience

October 17, 2014
Medical Communications, Sales and Marketing frost and sullivan, health, telehealth, videoconferencing, wearables

The telehealth industry is on the verge of a dramatic growth surge that is significantly disrupting the healthcare sector in …

Glivec image

Novartis cancer drug beating path to NHS

October 17, 2014
Sales and Marketing GIST, Glivec, NHS, NICE, imatinib, uturn

NICE has issued final draft guidance recommending Novartis’s Glivec for up to three years in people who have had a …

Four promotions at Red Door Communications

October 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kate Aldous, Katy Pogson, Matt Lowe, Red Door Communications, Sarah Aldridge

Red Door Communications (RDC) has promoted Matt Lowe and Katy Pogson to its board of directors, and Kate Aldous and …

Roche image

New cancer drugs escalate Roche earnings

October 16, 2014
Research and Development, Sales and Marketing Cancer, Herceptin (trastuzumab), Kadcyla, Perjeta, Q3, Roche, ado-trastuzumab emtansine, pertuzumab

Roche’s sales saw solid growth in the first nine months of the year, increased by the firm’s new cancer medicines. …

Astrazeneca's Cambridge Biomedical Campus

AstraZeneca deepens Cambridge ties

October 16, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, MRC, MedImmune

AstraZeneca along with its biologics R&D arm MedImmune are to enter into four new collaborations with the University of Cambridge. …

Boehringer image

Boehringer and Roche IPF drugs win FDA approval

October 16, 2014
Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, FDA, IPF, InterMune, Roche, US, lung scarring, lungs, ofev

The FDA has approved both Roche’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) for the treatment of the fatal lung …

NICE not recommending Dendreon cancer vaccine

October 16, 2014
Sales and Marketing Dendreon, NHS, NICE, Provenge, sipuleucel-T, therapeutic cancer vaccine

NICE has issued preliminary draft guidance not recommending Dendreon’s therapeutic cancer vaccine Provenge for prostate cancer in people whose disease …

The Gateway to Local Adoption Series

Latest content